Hi Wanda, there has been really encouraging results from targeted therapies for triple neg. I’ve just concluded chemo & immunotherapy for this and the results were excellent. In my case, I also have inflammatory breast cancer, so a mastectomy is still required, but prognosis for triple neg has improved considerably compared to some of the statistics you may read online.
June 1
Great question! Abraxane (paclitaxel albumin-bound) is a chemotherapy drug that can be used to treat metastatic triple-negative breast cancer (TNBC). It works by stopping cancer cells from dividing and growing.
For metastatic TNBC, chemotherapy is often the first line of treatment since TNBC cells lack the receptors that Show Full Answer
Great question! Abraxane (paclitaxel albumin-bound) is a chemotherapy drug that can be used to treat metastatic triple-negative breast cancer (TNBC). It works by stopping cancer cells from dividing and growing.
For metastatic TNBC, chemotherapy is often the first line of treatment since TNBC cells lack the receptors that hormone therapies and some targeted treatments rely on. Abraxane may be used:
- Alone as a chemotherapy treatment
- In combination with other drugs, such as immunotherapy (like pembrolizumab/Keytruda) if your cancer cells have a protein called PD-L1
- Alongside other chemotherapy agents depending on how your cancer is behaving
It's really important to talk with your oncologist about whether Abraxane is the right fit for your specific situation, including your overall health and treatment history. They can help tailor the best plan for you. 💙
June 1